RefCheck Maintenance Notice

On Monday, December 3, 2018, from 16:00-18:00 EST, RefCheck will be undergoing maintenance. RefCheck is the process where, during copyediting, all references are extracted from the manuscript file, parsed, matched against various databases (eg, PubMed and CrossRef), and automatically corrected. For more information on RefCheck, please visit our Knowledge Base.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 21.02.17 in Vol 5, No 2 (2017): February

This paper is in the following e-collection/theme issue:

Works citing "Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia"

According to Crossref, the following articles are citing this article (DOI 10.2196/mhealth.7030):

(note that this is only a small subset of citations)

  1. Mak K, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today 2018;
  2. Fogel AL, Kvedar JC. Artificial intelligence powers digital medicine. npj Digital Medicine 2018;1(1)
  3. Steinkamp J, Goldblatt N, Borodovsky JT, LaVertu A, Kronish I, Marsch LA, Schuman-Olivier Z. Technological interventions for medication adherence in adult mental health and substance use disorders: a systematic scoping review (Preprint). JMIR Mental Health 2018;
  4. McCaul ME, Wand GS. Detecting Deception in Our Research Participants: Are Your Participants Who You Think They Are?. Alcoholism: Clinical and Experimental Research 2018;42(2):230
  5. Boehme P, Wienand P, Herrmann M, Truebel H, Mondritzki T. New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next century. Medical Hypotheses 2017;108:46